Fresenius Kabi announced today that it will acquire Ivenix with plans to bring a comprehensive infusion product portfolio to the U.S. The acquisition, which has a purchase price of $240 million upfront, also includes potential milestone payments linked to achievements of commercial and operating targets. Get the full story at our sister site, Drug Delivery Business News.
Ivenix
Fort HealthCare, Ivenix partner on infusion safety effort with smart pump
Ivenix announced today that it successfully implemented its smart infusion pump at the Fort HealthCare hospital in Wisconsin. Boston-based Ivenix designed its Ivenix Infusion System, a combination of a large-volume infusion pump and infusion management software, to offer unique capabilities within the infusion therapy market, with pumps deployed at Fort HealthCare set to connect with the […]
Smiths Medical partners with Ivenix on infusion management suite
Smiths Medical announced today that it partnered with Ivenix to offer a comprehensive suite of infusion management solutions. Minneapolis-based Smiths Medical will provide a strategic investment for the long-term partnership that intends to “revolutionize” infusion management and improve patient safety while meeting the needs of healthcare providers, according to a news release. Get the full story at our […]
Next COVID-19 device shortage? ‘Smart’ infusion pumps
Severely ill COVID-19 patients may need multiple medications delivered by infusion pumps. Manufacturers and hospitals are planning on how to avoid shortages of these pumps and the associated tubing. You’ve likely seen the videos of ICU hallways lined with medical devices that would normally be in patient rooms. Among them are machines that are ubiquitous […]
Ivenix wins 510(k) clearance for infusion system
Ivenix said today that its infusion system won 510(k) clearance from the FDA. The large-volume pump and infusion system features a “smartphone-like” user interface and a suite of administration tools to remotely monitor infusions, according to Ivenix. Get the full story at our sister site, Drug Delivery Business News.
Ivenix pulls down $10m tranche in $50m round
Ivenix raised $10 million in equity from 18 unnamed investors in the 1st tranche of its $50 million round, according to regulatory filings. The company indicated that it does not expect the offering to exceed 1 year. It has not made a formal statement about how it plans to spend the newly-acquired funds. The Massachusetts-based start-up […]
Ivenix CEO Randle looks to reboot the infusion pump
Ivenix CEO Stuart Randle began his foray into drug pump delivery systems at Baxter in 1988, when he led the company’s effort to develop the 1st needle-free IV system. More than 20 years later, when he was approached about the corner office at Ivenix, Randle revisited the infusion pump industry and saw that the technology had not kept up […]
Ivenix taps ex-GI Dynamics chief Randle for CEO | Personnel Moves
Ivenix said in named former GI Dynamics (ASX:GID) chief Stuart Randle to be its new CEO. Randle departed GI Dynamics in August 2014, after 10 years with the bariatric device maker. Amesbury, Mass.-based Ivenix, which raised $42 million last September, is developing an infusion management system for hospitals that will combine an information technology interface […]
Ivenix raises $42m for drug infusion technology
Drug infusion device developer Ivenix said today it closed a $42 million round of equity financing to support the company’s efforts to enter the global drug infusion market. Ivenix is developing an infusion management system for hospitals that will combine an information technology interface along with an adaptive fluid delivery platform, the company said. The company hopes […]
